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1. Introduction 
Although glycogen phosphorylase (EC 2.4.1 .l) 
from rabbit muscle has been subjected to the most 
detailed analysis of structure, mechanism and func- 
tion, other glycogen phosphorylases have received 
less attention. The human brain enzyme in particular, 
has been neglected in many respects. It is known that 
this tissue contains three isoenzymes which corre- 
spond to a predominant brain type, muscle type, and 
a hybrid of the two [1,2]. Here, we have investigated 
the characteristics of human brain phosphorylase by 
means of gel-exclusion chromatography and sucrose 
density gradient sedimentation. Both phosphorylase 
a and b appear to exist in a highMr form of -400 000 
and a low Mr form whose apparent size differs with 
the method of determination. Although the nature of 
the high MI form is not known, we believe that it 
reflects a previously unknown property of human 
brain phosphorylase. The low M, form is probably an 
equilibrium mixture of dimer and monomer which 
gives different apparent Mr-values depending upon 
the position of equilibrium. 
For gel-exclusion chromatography the extract was 
treated as described in the text and a 1.5 ml aliquot 
containing 300 mg sucrose was layered on a 1.4 cm X 
94 cm column of Sephacryl S-300 (Pharmacia, 
Uppsala) equilibrated with a buffer containing 0.20 M 
Tris-HCl (PH 7.2) 0.20 M NaCl, and 5 mM 2-mer- 
captoethanol. The column was eluted with the same 
buffer at 5°C with a flow rate of 12 ml/h and frac- 
tions of 1.5 ml were collected. 
Sucrose density gradient sedimentation was done 
as in [3] with a SW 50.1 rotor, using 4.6 ml gradients 
of 5-20% sucrose containing 5 mM 2-mercapto- 
ethanol and indicated concentrations of Tris-HCl 
(pH 7.2) and NaCl. The gradients were collected in 
0.20 ml fractions. 
Phosphorylase was assayed as in [4] in a final 
volume of 50 fl; 2 mM AMP was included for the 
assay of phosphorylase b. Orthophosphate was deter- 
mined as in [5]. 
3. Results 
2. Materials and methods 
Samples of human cerebral cortex were kindly 
supplied by Dr Lucien Cote and by the Neuro-Tissue 
Facility (Department of Pathology, Columbia Univer- 
sity NY). Tissues were obtained at autopsy and stored 
frozen for up to several years, except for one sample 
which was used without prior freezing. Tissue extracts 
were prepared by homogenizing at 5°C with 2.5 vol. 
15 mM 2-mercaptoethanol and 0.1 mM phenylmeth- 
anesulfonyl fluoride using a motor-driven teflon 
pestle, and centrifuging at 20 000 X g for 20 min. 
Chromatography of an untreated extract of human 
brain on a column of Sephacryl S-300 resulted in the 
appearance of two sharp, symmetrical peaks of phos- 
phorylase b activity (fig.1). The high J4, component 
(Ph I) had -1 O-1 5% phosphorylase a activity, while 
the lowM, component (Ph II) was free of phosphoryl- 
ase a. Calibration was done with standard proteins; 
Ph I had an apparent Mr of 380 000, while that of 
Ph II was 71 000. The same pattern was observed in 
samples from 4 different individuals, including one in 
which the tissue was extracted without prior freezing. 
Extraction of tissue with buffer containing 5 mM 
mercaptoethanol, 0.2 M Tris-HCl (pH 7.2) and 0.2 M 
NaCl gave the same result. 
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Fig.1. Chromatogram of untreated human brain extract on Sephacryl S-300. Assay was with 20 ~1 aliquots for 1 h at 37°C. Total 
phosphorylase activity (0); phosphorylase a (0); A,,,-values (---). 
A similar extract prepared from frozen rabbit 
brain gave a single peak of phosphorylase activity 
with Mr 87 000 in this system. Extracts of rabbit 
muscle and liver and purified rabbit muscle phos- 
phorylase b all gave single peaks of phosphorylase 
activity with closely similar Mr-values (130 000). 
Human muscle extracts showed a single component 
with Mr of - 110 000. In view of the results obtained 
in sedimentation experiments and the known M, of 
rabbit muscle phosphorylase b (dimer, 194 664) [6], 
it seems likely that some of the M,-values obtained in 
this way are low, possibly because of interactions of 
the phosphorylases with the gel matrix of Sephacryl. 
The very low apparent M,-values for Ph II and the 
rabbit brain enzyme point to significant dissociation 
to monomer at these low concentrations (-1 EU/ml 
extract): 
Sucrose density gradient sedimentation experi- 
ments were carried out with the untreated extract, 
using 0.20 M Tris-HCl and 0.20 M NaCl in the gradi- 
ent. The two forms of phosphorylase from human 
brain extract are well separated (fig.2) and show 
approximate s20 w values of 14.3 S and 7.0 S. These 
correspond to M; of - 400 000 and 136 000, respec- 
tively. Pure rabbit muscle phosphorylase b gave an 
s20 w of 8.3 in this system; reported values of sZo w 
180 
for rabbit muscle phosphorylase a (tetramer) and b 
(dimer) are 13.5 S and 8.42 S, respectively [7]. 
Phosphorylase a activity coincided with the high 
molecular weight form (Ph I) and, in this case, repre- 
sented 40% of the total activity of the peak. When 
the experiment was done using only 50 mM Tris-HCl 
in the gradient, the high M, form was absent. 
Incubation of the crude human brain extract at 
37°C for 10 min resulted in loss of the Ph I com- 
ponent in both gel-exclusion and sedimentation experi- 
ments. However, the Ph II peak in the sucrose gradient 
increased in activity, suggesting conversion of Ph I to 
Ph II. The increase in Ph II activity was greater than 
the loss of Ph I activity, so the conclusion must be 
considered tentative. When fractions from gel-exclu- 
sion chromatography containing Ph I were combined, 
precipitated with (NH4)2S04 (50% of saturation), 
and rechromatographed, Ph I appeared in its charac- 
teristic position but there was no trace of Ph II. This 
suggests that the loss of Ph I is a result of enzymatic 
action during incubation, rather than simple dissocia- 
tion to Ph II. Loss of Ph I was not prevented by 
inclusion of 50 mM NaF or 10 mM EDTA during 
extraction and incubation. 
Incubation of crude brain extract at 4°C for 1 h 
with porcine pancreatic cu-amylase and Diazyme (mix- 
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Fig,& Sucrose density gradient sedimentation of untreated human brain extract. Sampie was 0.20 ml and run was 17 h at 
27 000 rev./mitt. Assay was with 10 4 &quo& for 1 h at 30°C. Total phosphorylase activity fo); ~ho~pho~~~ a (0). Gradient 
contains 0.20 M Tris-HCI (pH 7.2) and 0.20 M NaCl. Arrows indicate peak Positions of intern& standards: PK, rabbit muscle 
pyruvate kinase, &fr 237 000, s20,w 10.4 S; LDH, rabbit muscle iactate dehydrogenase, Mr 144 000, ~20,~ 7.6 S. 
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Fig.3. Sephacryl S-300 chromatogram of human brain extract treated with phosphorylase kinase, Assay was with 20 ~1 aliquots 
for 1 h at 37°C. Total phosphorylase activity (o); phospho~lase  (*). 
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ture of glucosidases [S]) caused no change in the 
chromatographic pattern. This argues against Ph I 
being a complex containing an cr-glucan, since both 
enzymes are capable of digesting a-glucans. 
An attempt was made to activate the crude human 
brain phosphorylase with endogenous kinases by 
incubating the crude extract for 10 min at 37°C in 
the presence of 10 mM 2glycerophosphate (PH 6.8) 
5 mM Mg(Ac)Z, 10 PM cyclic AMP, 0.6 mM ATP, 
7.5 mM theophylline and 20 mM NaF. Chromatog- 
raphy revealed the loss of Ph I and the appearance of 
a small peak of phosphorylase a activity with Mr 
115 000; Ph II was unaffected. A similar experiment 
carried out with added rabbit muscle phosphorylase 
kinase (Sigma) (3 EU/ml), 10 mM 2glycerophosphate 
@H 6.8), 5 mM Mg(Ac)*, 3 mM ATP and 20 mM 
NaF is shown in fig.3. Phosphorylase a activity appeared 
as a double peak: one peak was in the position of 
Ph I while the second showed Mr - 120 000. There 
was no separate peak corresponding to Ph II. 
4. Discussion 
Human brain phosphorylase can exist in the high 
Mr species designated Ph I in either the a or b forms. 
Although the apparent M, of Ph I suggests that it is 
a tetramer, it remains possible that Ph I is a complex 
between phosphorylase dimer (or monomer) and 
other proteins. Conversion of Ph I to Ph II during 
incubation of the crude brain extract is probably 
catalyzed by an endogenous enzyme acting upon the 
phosphorylase polypeptide or other components of 
the complex. There is no evidence for the presence of 
a high MI form of phosphorylase b in rabbit brain or 
any other tissue. 
Brain phosphorylase a can also exist in a form the 
M, of which suggests it to be dimeric. Phosphorylase b, 
besides occurring in the Ph I form, exists in a low MI 
form (Ph 11) which is probably mostly monomer. Phos- 
phorylase b monomer has been demonstrated in 
extract of rat brain [9]; isolated monomer reverted 
to a mixture of dimer and monomer [9]. The monomer 
of rabbit muscle phosphorylase is inactive under con- 
ditions where it cannot reassociate to dimer [lo]. In 
the case of human brain phosphorylase b we cannot 
conclude from our results whether the monomer 
is active as such, is in equilibrium with active dimer, 
or forms an active dimer in the presence of the sub- 
strates. 
The distribution of phosphorylase isoenzymes 
[ 1,2] between Ph I and Ph II is under investigation. 
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